Themis Medicare
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
CTL Trusteeship Limited, acting as debenture trustee for OSS Software Solutions Labs Private Limited, disclosed the creation of a pledge over 2,53,17,620 equity shares of Themis Medicare Limited, representing 27.49% of the company's share capital. The pledge was made by Vividhmargi Trust, whose trustees include Dinesh Patel, Jayshree Patel and Sachin Patel, in connection with a debenture issuance by OSS Software on June 29, 2026.
Powered by Tijori
CTL Trusteeship Limited, acting as debenture trustee for OSS Software Solutions Labs Private Limited, disclosed the creation of a pledge over 2,53,17,620 equity shares of Themis Medicare Limited, representing 27.49% of the company's share capital. The pledge was made by Vividhmargi Trust, whose trustees include Dinesh Patel, Jayshree Patel and Sachin Patel, in connection with a debenture issuance by OSS Software on June 29, 2026.
Powered by Tijori
Nov 19 (Reuters) - Themis Medicare Ltd THEM.NS:
RECEIVED TAX DEMAND OF 41.8 MILLION RUPEES
Source text: ID:nBSEW1vsV
Further company coverage: THEM.NS
(([email protected];))
Nov 19 (Reuters) - Themis Medicare Ltd THEM.NS:
RECEIVED TAX DEMAND OF 41.8 MILLION RUPEES
Source text: ID:nBSEW1vsV
Further company coverage: THEM.NS
(([email protected];))
Nov 18 (Reuters) - Themis Medicare Ltd THEM.NS:
THEMIS MEDICARE LTD - AMALGAMATION OF GUJARAT THEMIS BIOSYN LIMITED WITH THEMIS MEDICARE
THEMIS MEDICARE- TML WILL ISSUE 118 SHARES FOR EVERY 100 SHARES HELD BY IN GTBL
Source text: ID:nBSE4r0y7D
Further company coverage: THEM.NS
(([email protected];))
Nov 18 (Reuters) - Themis Medicare Ltd THEM.NS:
THEMIS MEDICARE LTD - AMALGAMATION OF GUJARAT THEMIS BIOSYN LIMITED WITH THEMIS MEDICARE
THEMIS MEDICARE- TML WILL ISSUE 118 SHARES FOR EVERY 100 SHARES HELD BY IN GTBL
Source text: ID:nBSE4r0y7D
Further company coverage: THEM.NS
(([email protected];))
** Shares of Themis Medicare THEM.NS rise as much as 10.1% to a record high of 272.35 rupees
** THEM stock marks sharpest intraday climb since Feb26
** The pharma company on Friday reported a 35.7% climb in its June-quarter consolidated net profit of 246.8 mln rupees ($2.95 mln)
** "Consolidation in manpower in Active Pharmaceutical Ingredients(API) business and improved operational efficiencies led to higher margins," Managing Director Sachin Patel says
** More than 326,000 shares change hands, 3.2X the 30-day avg
** Stock last up 5.8%, taking YTD gains to 22.6%
($1 = 83.7150 Indian rupees)
(Reporting by Anisha Ajith in Bengaluru)
(([email protected];))
** Shares of Themis Medicare THEM.NS rise as much as 10.1% to a record high of 272.35 rupees
** THEM stock marks sharpest intraday climb since Feb26
** The pharma company on Friday reported a 35.7% climb in its June-quarter consolidated net profit of 246.8 mln rupees ($2.95 mln)
** "Consolidation in manpower in Active Pharmaceutical Ingredients(API) business and improved operational efficiencies led to higher margins," Managing Director Sachin Patel says
** More than 326,000 shares change hands, 3.2X the 30-day avg
** Stock last up 5.8%, taking YTD gains to 22.6%
($1 = 83.7150 Indian rupees)
(Reporting by Anisha Ajith in Bengaluru)
(([email protected];))
July 26 (Reuters) - Themis Medicare Ltd THEM.NS:
THEMIS MEDICARE JUNE-QUARTER CONSOL NET PROFIT 246.8 MILLION RUPEES
THEMIS MEDICARE JUNE-QUARTER CONSOL NET REVENUE FROM OPERATIONS 1.23 BILLION RUPEES
Source text for Eikon: ID:nBSEFyMDh
Further company coverage: THEM.NS
(([email protected];;))
July 26 (Reuters) - Themis Medicare Ltd THEM.NS:
THEMIS MEDICARE JUNE-QUARTER CONSOL NET PROFIT 246.8 MILLION RUPEES
THEMIS MEDICARE JUNE-QUARTER CONSOL NET REVENUE FROM OPERATIONS 1.23 BILLION RUPEES
Source text for Eikon: ID:nBSEFyMDh
Further company coverage: THEM.NS
(([email protected];;))
** Shares of pharmaceutical firm Themis Medicare THEM.NS up 8.5% to a record high of 234 rupees
** The reason for the move was not immediately clear
** Stock above 200- day moving avg since Nov. 9, 2023
** More than 347,000 shares traded, 1.6x the 30-day avg
** In Q3, stock was up for the fourth straight quarter
** THEM climbed ~58% in 2023, its fourth straight year of gains
(Reporting by Aleef Jahan in Bengaluru)
** Shares of pharmaceutical firm Themis Medicare THEM.NS up 8.5% to a record high of 234 rupees
** The reason for the move was not immediately clear
** Stock above 200- day moving avg since Nov. 9, 2023
** More than 347,000 shares traded, 1.6x the 30-day avg
** In Q3, stock was up for the fourth straight quarter
** THEM climbed ~58% in 2023, its fourth straight year of gains
(Reporting by Aleef Jahan in Bengaluru)
May 4 (Reuters) - Themis Medicare Ltd THEM.NS:
TO CONSIDER SUB-DIVISION OF SHARES
Source text for Eikon: ID:nBSE20GvPH
Further company coverage: THEM.NS
(([email protected];))
May 4 (Reuters) - Themis Medicare Ltd THEM.NS:
TO CONSIDER SUB-DIVISION OF SHARES
Source text for Eikon: ID:nBSE20GvPH
Further company coverage: THEM.NS
(([email protected];))
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Themis Medicare do?
Themis Medicare Ltd. is a research-based pharmaceutical company focusing on Pain Management, Critical Care, and Anti-Infectives. It develops differentiated products for patient benefit.
Who are the competitors of Themis Medicare?
Themis Medicare major competitors are Kopran, Bajaj Healthcare, Shree Ganesh Remed., Haleos Labs, Everest Organics, NGL Fine-Chem, Nectar Lifesciences. Market Cap of Themis Medicare is ₹1,068 Crs. While the median market cap of its peers are ₹866 Crs.
Is Themis Medicare financially stable compared to its competitors?
Themis Medicare seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Themis Medicare pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Themis Medicare latest dividend payout ratio is 15.43% and 3yr average dividend payout ratio is 11.36%
How has Themis Medicare allocated its funds?
Companies resources are allocated to majorly unproductive assets like Inventory
How strong is Themis Medicare balance sheet?
Balance sheet of Themis Medicare is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Themis Medicare improving?
No, profit is decreasing. The profit of Themis Medicare is -₹12.9 Crs for TTM, ₹29.83 Crs for Mar 2025 and ₹43.52 Crs for Mar 2024.
Is the debt of Themis Medicare increasing or decreasing?
Yes, The net debt of Themis Medicare is increasing. Latest net debt of Themis Medicare is ₹90.94 Crs as of Mar-26. This is greater than Mar-25 when it was ₹57.36 Crs.
Is Themis Medicare stock expensive?
Yes, Themis Medicare is expensive. Latest PE of Themis Medicare is 933, while 3 year average PE is 50.42. Also latest EV/EBITDA of Themis Medicare is 2934 while 3yr average is 108.
Has the share price of Themis Medicare grown faster than its competition?
Themis Medicare has given lower returns compared to its competitors. Themis Medicare has grown at ~14.85% over the last 8yrs while peers have grown at a median rate of 15.9%
Is the promoter bullish about Themis Medicare?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Themis Medicare is 67.11% and last quarter promoter holding is 67.11%.
Are mutual funds buying/selling Themis Medicare?
There is Insufficient data to gauge this.